Analysis Note
To view the Certificate of Analysis for this product, please visit www.cytiva.com.
Features and Benefits
Withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH. Novel ligand design gives enhanced protease resistance resulting in lower ligand leakage. Oriented coupling of recombinant Protein A to the matrix via an engineered C-terminal cysteine enhances IgG binding capacity. Fewer regulatory concerns due to the total absence of mammalian culture in the ligand production and purification. Prepacked HiTrap® columns for process development, screening of purification conditions, and small-scale purification of Mabs.
General description
HiTrap® MabSelect™ SuRe™ columns are prepacked with MabSelect™ SuRe, a BioProcess medium for purification of monoclonal antibodies from large sample volumes. The novel alkali-tolerant recombinant Protein A ligand allow cleaning-in-place (CIP).HiTrap® MabSelect™ columns are prepacked with MabSelect™ a bioprocess medium for capuring of Mabs from large sample volumes.
Legal Information
MabSelect SuRe is a trademark of Cytiva
SuRe is a trademark of Cytiva
Free MabSelect SuRe Ligand"MabSelect SuRe Ligand Restricted License" and "Cys-rProtein A Ligand Restricted License" are protected by the following patents and equivalent patents and patent applications in other countries: US 6,399,750 and EP 1123389. A free, non-transferable limited license to use this product for internal analytical purposes only accompanies the purchase of the product from a Cytiva company and its licensed distributors. Any other use will require a separate license from a Cytiva company.
MabSelect is a trademark of Cytiva
HiTrap is a registered trademark of Cytiva
This product has met the following criteria to qualify for the following awards: